160 related articles for article (PubMed ID: 22947870)
1. Calmodulin binds a highly extended HIV-1 MA protein that refolds upon its release.
Taylor JEN; Chow JYH; Jeffries CM; Kwan AH; Duff AP; Hamilton WA; Trewhella J
Biophys J; 2012 Aug; 103(3):541-549. PubMed ID: 22947870
[TBL] [Abstract][Full Text] [Related]
2. Calmodulin disrupts the structure of the HIV-1 MA protein.
Chow JY; Jeffries CM; Kwan AH; Guss JM; Trewhella J
J Mol Biol; 2010 Jul; 400(4):702-14. PubMed ID: 20488189
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of calmodulin bound to the binding domain of the HIV-1 matrix protein.
Vlach J; Samal AB; Saad JS
J Biol Chem; 2014 Mar; 289(12):8697-705. PubMed ID: 24500712
[TBL] [Abstract][Full Text] [Related]
4. NMR, biophysical, and biochemical studies reveal the minimal Calmodulin binding domain of the HIV-1 matrix protein.
Samal AB; Ghanam RH; Fernandez TF; Monroe EB; Saad JS
J Biol Chem; 2011 Sep; 286(38):33533-43. PubMed ID: 21799007
[TBL] [Abstract][Full Text] [Related]
5. Solution X-ray scattering reveals a novel structure of calmodulin complexed with a binding domain peptide from the HIV-1 matrix protein p17.
Izumi Y; Watanabe H; Watanabe N; Aoyama A; Jinbo Y; Hayashi N
Biochemistry; 2008 Jul; 47(27):7158-66. PubMed ID: 18553937
[TBL] [Abstract][Full Text] [Related]
6. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
[TBL] [Abstract][Full Text] [Related]
7. Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure.
Ghanam RH; Fernandez TF; Fledderman EL; Saad JS
J Biol Chem; 2010 Dec; 285(53):41911-20. PubMed ID: 20956522
[TBL] [Abstract][Full Text] [Related]
8. Maturation of the matrix and viral membrane of HIV-1.
Qu K; Ke Z; Zila V; Anders-Össwein M; Glass B; Mücksch F; Müller R; Schultz C; Müller B; Kräusslich HG; Briggs JAG
Science; 2021 Aug; 373(6555):700-704. PubMed ID: 34353956
[TBL] [Abstract][Full Text] [Related]
9. Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH.
Fledderman EL; Fujii K; Ghanam RH; Waki K; Prevelige PE; Freed EO; Saad JS
Biochemistry; 2010 Nov; 49(44):9551-62. PubMed ID: 20886905
[TBL] [Abstract][Full Text] [Related]
10. Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation.
Barros M; Heinrich F; Datta SAK; Rein A; Karageorgos I; Nanda H; Lösche M
J Virol; 2016 May; 90(9):4544-4555. PubMed ID: 26912608
[TBL] [Abstract][Full Text] [Related]
11. Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth.
Caccuri F; Giagulli C; Reichelt J; Martorelli D; Marsico S; Bugatti A; Barone I; Rusnati M; Guzman CA; Dolcetti R; Caruso A
J Virol; 2014 May; 88(10):5706-17. PubMed ID: 24623414
[TBL] [Abstract][Full Text] [Related]
12. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions.
Scarlata S; Ehrlich LS; Carter CA
J Mol Biol; 1998 Mar; 277(2):161-9. PubMed ID: 9514761
[TBL] [Abstract][Full Text] [Related]
13. Calmodulin and HIV type 1: interactions with Gag and Gag products.
Radding W; Williams JP; McKenna MA; Tummala R; Hunter E; Tytler EM; McDonald JM
AIDS Res Hum Retroviruses; 2000 Oct; 16(15):1519-25. PubMed ID: 11054265
[TBL] [Abstract][Full Text] [Related]
14. Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.
Jones CP; Datta SA; Rein A; Rouzina I; Musier-Forsyth K
J Virol; 2011 Feb; 85(4):1594-603. PubMed ID: 21123373
[TBL] [Abstract][Full Text] [Related]
15. Electrostatic interactions and binding orientation of HIV-1 matrix studied by neutron reflectivity.
Nanda H; Datta SA; Heinrich F; Lösche M; Rein A; Krueger S; Curtis JE
Biophys J; 2010 Oct; 99(8):2516-24. PubMed ID: 20959092
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
17. A high pressure study of calmodulin-ligand interactions using small-angle X-ray and elastic incoherent neutron scattering.
Cinar S; Al-Ayoubi S; Sternemann C; Peters J; Winter R; Czeslik C
Phys Chem Chem Phys; 2018 Jan; 20(5):3514-3522. PubMed ID: 29336441
[TBL] [Abstract][Full Text] [Related]
18. RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production.
Ramalingam D; Duclair S; Datta SA; Ellington A; Rein A; Prasad VR
J Virol; 2011 Jan; 85(1):305-14. PubMed ID: 20980522
[TBL] [Abstract][Full Text] [Related]
19. Relationships between MA-RNA Binding in Cells and Suppression of HIV-1 Gag Mislocalization to Intracellular Membranes.
Thornhill D; Olety B; Ono A
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511376
[TBL] [Abstract][Full Text] [Related]
20. A temporospatial map that defines specific steps at which critical surfaces in the Gag MA and CA domains act during immature HIV-1 capsid assembly in cells.
Robinson BA; Reed JC; Geary CD; Swain JV; Lingappa JR
J Virol; 2014 May; 88(10):5718-41. PubMed ID: 24623418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
